Michael Vinegrad Email
Group Communications Director . Avacta
,
LocationPrimary Email
How to contact Michael Vinegrad
Join and see Michael's contact info for free!Current Roles
Employees:
370Revenue:
$57.4MAbout
Custom antibody alternative, Antibody alternatives, Afinnity reagents Avacta has developed Affimer technology - a revolutionary new engineered affinity protein that is an alternative to antibodies. Affimer molecules have been developed for applications in diagnostics, drug / biomarker discovery, biotech research and development and therapeutics. Find out more on our website.Avacta Address
Thorp Arch Estate, null
UK